The purpose of is to minimize the domination number of while tries to maximize it. If both and play according to their optimal strategies, is well defined. We call this
number the game domination subdivision number of and denote it by . In this paper we initiate the study of the game domination subdivision number of a graph and present sharp bounds on the game domination subdivision number of a tree.”
“Background: BAY 73-4506 inhibitor The interactions between metastatic breast cancer cells and host cells of osteoclastic lineage in bone microenvironment are essential for osteolysis. In vitro studies to evaluate pharmacological agents are mainly limited to their direct effects on cell lines. To mimic the communication between breast cancer cells
and human osteoclasts, a simple and reproducible cellular model was established to evaluate the effects of zoledronate (zoledronic acid, ZOL), a bisphosphonate which exerts antiresorptive properties.\n\nMethods: Human precursor osteoclasts were cultured on bone-like surfaces in the presence of stimuli (sRANKL, M-CSF) to ensure their activation. Furthermore, immature as well as activated osteoclasts were co-cultured with MDA-MB-231 breast cancer cells. TRAP5b and type I collagen N-terminal telopeptide (NTx) were used as markers. Osteoclasts’ adhesion to bone surface AG-120 in vitro and subsequent bone breakdown were evaluated by studying the expression of cell surface receptors and certain functional matrix macromolecules in the presence of ZOL\n\nResults: ZOL significantly suppresses the precursor osteoclast maturation, even when the activation stimuli (sRANKL
and M-SCF) are present. Moreover, it significantly decreases bone osteolysis and activity of MMPs as well as precursor osteoclast maturation by breast cancer cells. Additionally, ZOL inhibits the osteolytic activity of mature osteoclasts and the expression of integrin beta 3, matrix metalloproteinases and cathepsin K, all implicated in adhesion and bone resorption.\n\nConclusions: ZOL exhibits a beneficial inhibitory effect by restricting activation of osteoclasts, bone particle decomposition and the MMP-related breast cancer osteolysis.\n\nGeneral significance: The proposed cellular model can be reliably used for enhancing preclinical CDK inhibitor drugs evaluation of pharmacological agents in metastatic bone disease. (C) 2013 Elsevier B.V. All rights reserved.”
“Background and Aims:\n\nHepatic venous pressure gradient (HVPG) has been established as a predictor for the development of varices, clinical decompensation and death. In the present study, the primary objectives were to determine the diagnostic accuracy of the model developed by using readily-available data in predicting the presence of significant portal hypertension and esophageal varices.\n\nMethods:\n\nThis study included a total of 61 consecutive treatment-naive patients with advanced fibrosis (METAVIR F3, F4), established by liver biopsy.